Lymphoma and other cancers may occur when a delicate gene recombination process in antibody-making cells goes awry, according to preliminary studies in mice at the University of Michigan.
Thousands of scientists and hundreds of software programmers studying the process by which RNA inside cells normally degrades may soon broaden their focus significantly.
Traditional rice cultivation methods practiced in the isolated hillside farms of Thailand are helping preserve the genetic diversity of rice, one of the world's most important food crops, according to a new study by researchers at Washington University in St. Louis and Chiang Mai University in Thailand.
In the race for faster, cheaper ways to read human genomes, Pacific Biosciences is hoping to set a new benchmark with technology that watches DNA being copied in real time. The device is being developed to sequence DNA at speeds 20,000 times faster than second-generation sequencers currently on the market and will ultimately have a price tag of $100 per genome.
Evidence buried in the chromosomes of animals and plants strongly suggests only one group -- mammals -- have seen their genomes shrink after the dinosaurs' extinction. What's more, that trend continues today, say Indiana University Bloomington scientists in the first issue of a new journal, Genome Biology and Evolution.
Switching off a key DNA repair system in the developing nervous system is linked to smaller brain size as well as problems in brain structures vital to movement, memory and emotion, according to new research led by St. Jude Children's Research Hospital scientists.
University of Utah researchers and their colleagues have identified the gene that is mutated in a hereditary form of a rare neuroendocrine tumor called paraganglioma (PGL). The gene, called hSDH5, is required for activation of an enzyme complex that plays a critical role in the chemical reactions that take place within cells to convert biochemical energy into usable energy.
Current electronic health records (EHRs) have a long way to go to meet the challenges of genetic/genomic medicine, reports a study in the July issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
University of North Carolina at Chapel Hill School of Medicine scientists have found what may be the most efficient way to deliver a corrected gene to lung cells collected from cystic fibrosis patients.
UCLA researchers have discovered the first genetic link to placebo: they report that in people suffering from Major Depressive Disorder, genes that influence the brain's reward pathways may modulate the response to placebos.
Researchers at the University of Rochester Medical Center have found a way to block the genetic flaw at the heart of a common form of muscular dystrophy. The results of the study, which were published today in the journal Science, could pave the way for new therapies that essentially reverse the symptoms of the disease.
Genetics researchers have unveiled a powerful new resource for scientists and health providers studying human illnesses--a reference standard of deletions and duplications of DNA found in the human genome. Drawn from over 2,000 healthy persons, the study provides one of the deepest and broadest sets of copy number variations available to date, along with a new research tool for rapid diagnosis.
Researchers from the UT Health Science Center San Antonio and other institutions crack the genetic code of Schistosoma mansoni, a flatworm that can live up to 10 years on average in humans. The parasite is endemic in many tropical areas of the world.
Research by a group of Montreal scientists calls into question one of the most basic assumptions of human genetics: that when it comes to DNA, every cell in the body is essentially identical to every other cell. Their results appear in the July issue of the journal Human Mutation.
With the advent of high-throughput DNA sequencing technologies, it is now possible to cheaply and rapidly sequence hundreds of millions of bases in a matter of hours. A team of scientists have developed molecular and computational tools for the efficient and accurate identification of gene-enriched SNPs in crops.
A Baylor University researcher has found a set of genes that modulates stress responses that could cause some people to take drugs, specifically alcohol consumption.
A Tufts University research team has created an experimental model that produces large-scale expansion of GAA repeats during DNA replication, which is the cause of Friedreich's Ataxia. With this model, the researchers are able to analyze GAA repeat expansions and then identify cellular proteins that thwarted normal replication and promoted the elongated sequence.
Mayo Clinic researchers and colleagues at the University of California San Francisco (UCSF) have found a connection between DNA alterations on human chromosome 9 and aggressive brain cancer known as glioblastoma.
A new UNC study appearing online July 1 in the journal Nature disputes current scientific belief by showing that X-inactivation can occur even in the absence of a gene previously thought to be the trigger of the process.
The finding suggests that schizophrenia is much more complex than previously thought and can arise not only from both rare genetic variants but also from a significant number of common ones.
An analysis of the association between genetic variations of the inflammation biomarker C-reactive protein (CRP) with coronary heart disease failed to support a causal association, according to a study in the July 1 issue of JAMA.
More pieces in the complex autism inheritance puzzle are emerging in the latest gene study of autism spectrum disorders (ASDs). This study identified 27 different genetic regions where rare copy number variations "“ missing or extra copies of DNA segments "“ occurred in the genes of children with ASDs, but not in healthy controls.
More pieces in the complex autism inheritance puzzle are emerging in the latest study from a research team including geneticists from the University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia (CHOP), and several collaborating institutions.
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream. According to a new Cornell study, the technique could one day be used to deliver vaccines, drugs or genetic material to treat cancer and blood and immunological disorders. (Gene Therapy online, June 25, 2009.)
Pediatric researchers have identified hundreds of gene variations that occur more frequently in children with attention-deficit hyperactivity disorder than in children without ADHD. Many of those genes were already known to be important for learning, behavior, brain function and neurodevelopment. This is the first study to investigate the role of copy number variations in ADHD.
Having partnered last year with an international team that surveyed the genomes of 12,000 individuals to find a genetic cause for gout, Johns Hopkins scientists now have shown that the malfunctioning gene they helped uncover can lead to high concentrations of blood urate that forms crystals in joint tissue, causing inflammation and pain "” the hallmark of this disease.
There is insufficient evidence to conclude that genetic testing for two gene mutations in adults with a history of blood clots helps to prevent deep-vein thrombosis.
Researchers at the Johns Hopkins School of Medicine have successfully edited the genome of human- induced pluripotent stem cells, making possible the future development of patient-specific stem cell therapies. Reporting this week in Cell Stem Cell, the team altered a gene responsible for causing the rare blood disease paroxysmal nocturnal hemoglobinuria, or PNH, establishing for the first time a useful system to learn more about the disease.
Researchers at the University of Virginia Health System have found a new way to study how genes function in living organisms, and their approach could substantially cut the time and costs that drug makers spend in searching for potential targets for new cancer therapies.
In pubic comments given today before the Secretary of Health and Human Services Advisory Committee on Genetics, Health and Society (SACGHS), the Association for Molecular Pathology (AMP) addressed three areas: Comparative Effectiveness Research (CER), evidence for coverage of genetic and genomic tests, and gene patents.
It was long believed that conception doesn't involve a meeting of equals. The egg is a relatively large biological factory compared with the tiny sperm. However, a new study from Huntsman Cancer Institute at the University of Utah reveals that the father's sperm delivers much more complex genetic material than previously thought. The findings could lead to a test to help couples deal with infertility.
Jumping genes do most of their jumping, not during the development of sperm and egg cells, but during the development of the embryo itself. The research challenges standard assumptions on the timing of when mobile DNA, so-called jumping genes, insert into the human genome.
Feinstein Institute for Medical Research and a team of collaborators from across the country have identified a new risk factor gene for rheumatoid arthritis. The gene, dubbed REL, is a member of the NF-(kappa)B family. The NF-(kappa)B family seems to have a big hand in regulating the body's immune response.
Boys who carry a particular variation of the gene Monoamine oxidase A (MAOA), sometimes called the "warrior gene," are more likely not only to join gangs but also to be among the most violent members and to use weapons, according to a new study from The Florida State University that is the first to confirm an MAOA link specifically to gangs and guns.
If you had cancer and a genetic test could predict the risk of aggressive metastasis, would you want to know "“ even if no treatments existed to help you? An overwhelming majority of eye cancer patients would answer yes, according to a new UCLA study published in the June edition of the Journal of Genetic Counseling.
New research shows that most parents who undergo genetic testing to assess their risk of breast cancer in particular, tell their young children of the results. The study, presented at the annual American Society of Clinical Oncology meeting, also looks at how parents perceive their child's reaction to such news.
Virginia Commonwealth University researchers have identified a gene that may play a key role in regulating tumor progression in neuroblastoma, a form of cancer usually found in young children. Scientists hope the finding could lead to an effective therapy to inhibit the expression of this gene.
Researchers at the University of Pennsylvania School of Medicine have uncovered variation around two genes that are associated with an increased risk of testicular cancer. Testicular cancer is the most common cancer among young men, and its incidence among non-Hispanic Caucasian men has doubled in the last 40 years -- it now affects seven out of 100,000 white men in the United States each year.
Researchers have discovered a novel molecular path that predisposes patients to develop primary biliary cirrhosis, a disease that mainly affects women and slowly destroys their livers. Primary biliary cirrhosis has no known cause.
A protein that plays a key role in tumor formation, oxygen metabolism and inflammation is involved in a pathway that extends lifespan by dietary restriction. The finding provides a new understanding of how dietary restriction contributes to longevity and cancer prevention and gives scientists new targets for developing and testing drugs that could extend the healthy years of life.
A simple genetic test can determine a kidney transplant patient's tolerance for a potent anti-rejection medication, according to an upcoming study in the Journal of the American Society Nephrology (JASN). The test could allow doctors to individualize each patient's dose, optimizing the drug's benefits and minimizing its side effects.
The American Civil Liberties Union filed a lawsuit (May 11) against the Patent and Trademark Office, Myriad Genetics, and the University of Utah Research Foundation for patenting two genes associated with hereditary breast and ovarian cancers. Yvonne Cripps, the Harry T. Ice Professor of Law at Indiana University Maurer School of Law, says this is likely to be a landmark case.
Our genome is a patchwork of neighborhoods that couldn't be more different: Some areas are hustling and bustling with gene activity, while others are sparsely populated and in perpetual lock-down. Breaking down just a few of the molecular fences that separate them blurs the lines and leads to the inactivation of at least two tumor suppressor genes, according to researchers at the Salk Institute for Biological Studies.
A popular view among evolutionary biologists that fundamental genes do not acquire new functions was challenged this week by a new study in the Proceedings of the National Academy of Sciences. Indiana University Bloomington biologist Armin Moczek and research associate Debra Rose report that two ancient genes were "co-opted" to help build a new trait in beetles -- the fancy antlers that give horned beetles their name.
In an international effort, scientists at the Illinois Institute of Technology together with industrial partners at DNAFORM in Japan, imaGenes in Germany, FASTERIS in Switzerland, and Precision Biomarker Resources in USA have for the first time prepared a genome-wide map of Transcription Start Sites (TSS) for the fruit fly Drosophila melanogaster.
University of Adelaide researchers in Australia are developing a world-first genetic test that can predict which pregnancies are at risk of complications long before symptoms arise.
An international team of researchers has identified three genes containing common mutations that are associated with altered kidney disease risk. One of the discovered genes, the UMOD gene, produces Tamm-Horsfall protein, the most common protein in the urine of healthy individuals. Although the Tamm-Horsfall protein has been known for almost 60 years, its functions are not well understood and its relationship to chronic kidney disease risk was not known previously.
DNA is damaged about 20,000 times a day. Sometimes this damage causes gaps that prevent the DNA molecule from being copied when the cell divides. In a sloppy but efficient repair technique, the cell may fill in the missing DNA in an inaccurate fashion. Such repair can save the cell from dying, but it comes at a price: this error-prone mechanism is a major source of mutations. Now, a scientist at the Weizmann Institute has revealed how the stopgap repair works. It proceeds in two steps and requires two types of enzymes.